POINT Biopharma Global Current Assets

POINT Biopharma Global (PNT) currently reports a current assets of $350M as of September 2023. That compares with $300M in the prior-year period — up 19.2% year over year. Use the charts on this page to explore POINT Biopharma Global's current assets history and peer comparisons.

POINT Biopharma Global's current assets increased from $300M to $350M — a 19.2% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

POINT Biopharma Global reported $350M in current assets as of September 2023. That compares with $300M in the prior-year period — up 19.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $350M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for POINT Biopharma Global, and consider following PNT for alerts when major investors trade the stock.

POINT Biopharma Global is classified in the Healthcare sector. On current assets, it currently shows $350M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PNT with unrelated industries.